HEADER TRANSFERASE 14-SEP-15 5AP0
TITLE NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO
TITLE 2 KINASE INHIBITOR DRUG RESISTANCE.
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 519-808;
COMPND 5 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE, PYT,
COMPND 6 MONOPOLAR SPINDLE KINASE 1;
COMPND 7 EC: 2.7.12.1;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21;
SOURCE 8 EXPRESSION_SYSTEM_VARIANT: AI
KEYWDS TRANSFERASE, MPS1, PROTEIN KINASE, MITOSIS, DRUG RESISTANCE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.D.GURDEN,I.M.WESTWOOD,A.FAISAL,S.NAUD,K.J.CHEUNG,C.MCANDREW,A.WOOD,
AUTHOR 2 J.SCHMITT,K.BOXALL,G.MAK,P.WORKMAN,R.BURKE,S.HOELDER,J.BLAGG,
AUTHOR 3 R.L.M.VAN MONTFORT,S.LINARDOPOULOS
REVDAT 3 16-OCT-24 5AP0 1 REMARK
REVDAT 2 10-JAN-24 5AP0 1 REMARK LINK
REVDAT 1 23-SEP-15 5AP0 0
JRNL AUTH M.D.GURDEN,I.M.WESTWOOD,A.FAISAL,S.NAUD,K.J.CHEUNG,
JRNL AUTH 2 C.MCANDREW,A.WOOD,J.SCHMITT,K.BOXALL,G.MAK,P.WORKMAN,
JRNL AUTH 3 R.BURKE,S.HOELDER,J.BLAGG,R.L.M.VAN MONTFORT,S.LINARDOPOULOS
JRNL TITL NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE
JRNL TITL 2 CELLS TO KINASE INHIBITOR DRUG RESISTANCE.
JRNL REF CANCER RES. V. 75 3340 2015
JRNL REFN ISSN 0008-5472
JRNL PMID 26202014
JRNL DOI 10.1158/0008-5472.CAN-14-3272
REMARK 2
REMARK 2 RESOLUTION. 2.15 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.4
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.12
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2
REMARK 3 NUMBER OF REFLECTIONS : 23673
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.186
REMARK 3 R VALUE (WORKING SET) : 0.184
REMARK 3 FREE R VALUE : 0.220
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090
REMARK 3 FREE R VALUE TEST SET COUNT : 1206
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 12
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.25
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.17
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2155
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2421
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2050
REMARK 3 BIN R VALUE (WORKING SET) : 0.2428
REMARK 3 BIN FREE R VALUE : 0.2286
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.87
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 105
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2025
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 135
REMARK 3 SOLVENT ATOMS : 59
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 58.67
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.03
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 2.28750
REMARK 3 B22 (A**2) : -1.90080
REMARK 3 B33 (A**2) : -0.38670
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.306
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.155
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.145
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.155
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.147
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2191 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 2934 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 768 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 56 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 317 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2191 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 279 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 2551 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.09
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.98
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.40
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 4
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: {A|515 - 561}
REMARK 3 ORIGIN FOR THE GROUP (A): -10.1026 8.8858 -20.8115
REMARK 3 T TENSOR
REMARK 3 T11: -0.2630 T22: -0.2402
REMARK 3 T33: 0.3028 T12: -0.0231
REMARK 3 T13: -0.0417 T23: 0.1520
REMARK 3 L TENSOR
REMARK 3 L11: 7.5040 L22: 6.5155
REMARK 3 L33: 3.5529 L12: -2.4152
REMARK 3 L13: -0.1942 L23: -1.6268
REMARK 3 S TENSOR
REMARK 3 S11: 0.0619 S12: -0.5442 S13: -0.5442
REMARK 3 S21: 0.1226 S22: 0.1970 S23: 0.3219
REMARK 3 S31: 0.5442 S32: -0.4598 S33: -0.2589
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: {A|562 - 620}
REMARK 3 ORIGIN FOR THE GROUP (A): -2.7519 18.6514 -22.6332
REMARK 3 T TENSOR
REMARK 3 T11: -0.1952 T22: -0.1860
REMARK 3 T33: 0.1823 T12: 0.0268
REMARK 3 T13: 0.0089 T23: 0.0669
REMARK 3 L TENSOR
REMARK 3 L11: 6.4896 L22: 3.1412
REMARK 3 L33: 1.3625 L12: 1.3232
REMARK 3 L13: 1.3955 L23: -1.0481
REMARK 3 S TENSOR
REMARK 3 S11: -0.0243 S12: -0.2682 S13: -0.2243
REMARK 3 S21: 0.1135 S22: 0.0971 S23: 0.0636
REMARK 3 S31: 0.0956 S32: -0.0550 S33: -0.0728
REMARK 3
REMARK 3 TLS GROUP : 3
REMARK 3 SELECTION: {A|621 - 712}
REMARK 3 ORIGIN FOR THE GROUP (A): 7.2901 25.8780 -17.5318
REMARK 3 T TENSOR
REMARK 3 T11: -0.2608 T22: -0.1920
REMARK 3 T33: 0.1612 T12: -0.0217
REMARK 3 T13: 0.0130 T23: 0.1075
REMARK 3 L TENSOR
REMARK 3 L11: 5.5099 L22: 3.6172
REMARK 3 L33: 3.3679 L12: 0.5397
REMARK 3 L13: 1.1491 L23: -1.0823
REMARK 3 S TENSOR
REMARK 3 S11: -0.0247 S12: -0.2668 S13: -0.1061
REMARK 3 S21: 0.1940 S22: -0.1032 S23: 0.1716
REMARK 3 S31: -0.1322 S32: -0.0180 S33: 0.1279
REMARK 3
REMARK 3 TLS GROUP : 4
REMARK 3 SELECTION: {A|713 - 794}
REMARK 3 ORIGIN FOR THE GROUP (A): 16.6672 32.1091 -10.2484
REMARK 3 T TENSOR
REMARK 3 T11: -0.2461 T22: -0.0947
REMARK 3 T33: 0.2048 T12: -0.1323
REMARK 3 T13: -0.1095 T23: 0.0695
REMARK 3 L TENSOR
REMARK 3 L11: 2.1355 L22: 2.4427
REMARK 3 L33: 4.6152 L12: -0.3316
REMARK 3 L13: -1.2095 L23: -1.1740
REMARK 3 S TENSOR
REMARK 3 S11: 0.0372 S12: -0.5442 S13: 0.2400
REMARK 3 S21: 0.5212 S22: -0.2858 S23: -0.4091
REMARK 3 S31: -0.4483 S32: 0.5197 S33: 0.2486
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5AP0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-SEP-15.
REMARK 100 THE DEPOSITION ID IS D_1290065025.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 04-AUG-10
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : DIAMOND
REMARK 200 BEAMLINE : I04
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : QUANTUM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23736
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150
REMARK 200 RESOLUTION RANGE LOW (A) : 41.120
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5
REMARK 200 DATA REDUNDANCY : 3.800
REMARK 200 R MERGE (I) : 0.06000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22
REMARK 200 COMPLETENESS FOR SHELL (%) : 72.9
REMARK 200 DATA REDUNDANCY IN SHELL : 2.60
REMARK 200 R MERGE FOR SHELL (I) : 0.70000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.700
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: PDB ENTRY 4C4J
REMARK 200
REMARK 200 REMARK: NONE
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 60.34
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (V/V) PEG300, PH 7.5
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X,Y,-Z
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z+1/2
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.46500
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.98000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 56.54500
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.46500
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.98000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.54500
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.46500
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.98000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.54500
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.46500
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.98000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.54500
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH A2005 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 496
REMARK 465 HIS A 497
REMARK 465 HIS A 498
REMARK 465 HIS A 499
REMARK 465 HIS A 500
REMARK 465 HIS A 501
REMARK 465 HIS A 502
REMARK 465 SER A 503
REMARK 465 SER A 504
REMARK 465 GLY A 505
REMARK 465 VAL A 506
REMARK 465 ASP A 507
REMARK 465 LEU A 508
REMARK 465 GLY A 509
REMARK 465 THR A 510
REMARK 465 GLU A 511
REMARK 465 ASN A 512
REMARK 465 LEU A 513
REMARK 465 TYR A 514
REMARK 465 GLN A 670
REMARK 465 MET A 671
REMARK 465 GLN A 672
REMARK 465 PRO A 673
REMARK 465 ASP A 674
REMARK 465 THR A 675
REMARK 465 THR A 676
REMARK 465 SER A 677
REMARK 465 VAL A 678
REMARK 465 VAL A 679
REMARK 465 LYS A 680
REMARK 465 ASP A 681
REMARK 465 SER A 682
REMARK 465 SER A 699
REMARK 465 SER A 700
REMARK 465 SER A 701
REMARK 465 ARG A 702
REMARK 465 GLU A 703
REMARK 465 ASN A 704
REMARK 465 GLY A 705
REMARK 465 LYS A 706
REMARK 465 SER A 707
REMARK 465 LYS A 708
REMARK 465 SER A 709
REMARK 465 LYS A 710
REMARK 465 HIS A 796
REMARK 465 PRO A 797
REMARK 465 VAL A 798
REMARK 465 ASN A 799
REMARK 465 GLN A 800
REMARK 465 MET A 801
REMARK 465 ALA A 802
REMARK 465 LYS A 803
REMARK 465 GLY A 804
REMARK 465 THR A 805
REMARK 465 THR A 806
REMARK 465 GLU A 807
REMARK 465 GLU A 808
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 PHE A 515 CG CD1 CD2 CE1 CE2 CZ
REMARK 470 GLN A 516 CG CD OE1 NE2
REMARK 470 LYS A 529 CE NZ
REMARK 470 SER A 533 OG
REMARK 470 SER A 536 OG
REMARK 470 LYS A 538 CD CE NZ
REMARK 470 LYS A 546 CG CD CE NZ
REMARK 470 LYS A 547 CE NZ
REMARK 470 GLU A 559 CG CD OE1 OE2
REMARK 470 GLN A 563 CD OE1 NE2
REMARK 470 LYS A 577 CE NZ
REMARK 470 LYS A 614 CE NZ
REMARK 470 LYS A 615 CG CD CE NZ
REMARK 470 LYS A 616 CD CE NZ
REMARK 470 LYS A 617 CG CD CE NZ
REMARK 470 SER A 618 OG
REMARK 470 VAL A 684 CG1 CG2
REMARK 470 LYS A 696 CE NZ
REMARK 470 ILE A 711 CG1 CG2 CD1
REMARK 470 GLU A 753 CD OE1 OE2
REMARK 470 GLU A 755 CG CD OE1 OE2
REMARK 470 LYS A 762 CD CE NZ
REMARK 470 LYS A 777 CD CE NZ
REMARK 470 THR A 795 CA C O CB OG1 CG2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 536 17.67 59.46
REMARK 500 LYS A 617 -74.41 -77.01
REMARK 500 SER A 646 -3.97 72.58
REMARK 500 LEU A 772 39.38 -96.86
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHANOL (7
REMARK 600 9-CYCLOPENTYL-2-[[2-METHOXY-4-[(1-METHYLPIPERIDIN-4-YL)OXY]-PHENYL]A
REMARK 610
REMARK 610 MISSING HETEROATOM
REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 610 I=INSERTION CODE):
REMARK 610 M RES C SSEQI
REMARK 610 P4C A 1797
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AU5 A 1795
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P4C A 1796
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P4C A 1797
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 1798
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 1799
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1800
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1801
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1802
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1803
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1804
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1805
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1806
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1807
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1808
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1809
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1810
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1811
REMARK 800
REMARK 800 SITE_IDENTIFIER: BC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1812
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 5AP1 RELATED DB: PDB
REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO
REMARK 900 KINASE INHIBITOR DRUG RESISTANCE.
REMARK 900 RELATED ID: 5AP2 RELATED DB: PDB
REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO
REMARK 900 KINASE INHIBITOR DRUG RESISTANCE.
REMARK 900 RELATED ID: 5AP3 RELATED DB: PDB
REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO
REMARK 900 KINASE INHIBITOR DRUG RESISTANCE.
REMARK 900 RELATED ID: 5AP4 RELATED DB: PDB
REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO
REMARK 900 KINASE INHIBITOR DRUG RESISTANCE.
REMARK 900 RELATED ID: 5AP5 RELATED DB: PDB
REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO
REMARK 900 KINASE INHIBITOR DRUG RESISTANCE.
REMARK 900 RELATED ID: 5AP6 RELATED DB: PDB
REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO
REMARK 900 KINASE INHIBITOR DRUG RESISTANCE.
REMARK 900 RELATED ID: 5AP7 RELATED DB: PDB
REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO
REMARK 900 KINASE INHIBITOR DRUG RESISTANCE.
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THE SEQUENCE INCLUDING HEXAHISTIDINE TAG IS AS DESCRIBED
REMARK 999 IN NAT. CHEM. BIOL. 2010, 6, 259-368.
DBREF 5AP0 A 519 808 UNP P33981 TTK_HUMAN 519 808
SEQADV 5AP0 MET A 496 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 HIS A 497 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 HIS A 498 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 HIS A 499 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 HIS A 500 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 HIS A 501 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 HIS A 502 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 SER A 503 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 SER A 504 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 GLY A 505 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 VAL A 506 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 ASP A 507 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 LEU A 508 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 GLY A 509 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 THR A 510 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 GLU A 511 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 ASN A 512 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 LEU A 513 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 TYR A 514 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 PHE A 515 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 GLN A 516 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 SER A 517 UNP P33981 EXPRESSION TAG
SEQADV 5AP0 MET A 518 UNP P33981 EXPRESSION TAG
SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU
SEQRES 2 A 313 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS
SEQRES 3 A 313 GLY ARG ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY
SEQRES 4 A 313 GLY SER SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS
SEQRES 5 A 313 GLN ILE TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA
SEQRES 6 A 313 ASP ASN GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA
SEQRES 7 A 313 TYR LEU ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE
SEQRES 8 A 313 ARG LEU TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR
SEQRES 9 A 313 MET VAL MET GLU CYS GLY ASN ILE ASP LEU ASN SER TRP
SEQRES 10 A 313 LEU LYS LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS
SEQRES 11 A 313 SER TYR TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE
SEQRES 12 A 313 HIS GLN HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA
SEQRES 13 A 313 ASN PHE LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP
SEQRES 14 A 313 PHE GLY ILE ALA ASN GLN MET GLN PRO ASP THR THR SER
SEQRES 15 A 313 VAL VAL LYS ASP SER GLN VAL GLY TPO VAL ASN TYR MET
SEQRES 16 A 313 PRO PRO GLU ALA ILE LYS ASP MET SER SER SER ARG GLU
SEQRES 17 A 313 ASN GLY LYS SER LYS SER LYS ILE SER PRO LYS SER ASP
SEQRES 18 A 313 VAL TRP SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR
SEQRES 19 A 313 GLY LYS THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER
SEQRES 20 A 313 LYS LEU HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU
SEQRES 21 A 313 PHE PRO ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU
SEQRES 22 A 313 LYS CYS CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER
SEQRES 23 A 313 ILE PRO GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN
SEQRES 24 A 313 THR HIS PRO VAL ASN GLN MET ALA LYS GLY THR THR GLU
SEQRES 25 A 313 GLU
MODRES 5AP0 TPO A 686 THR PHOSPHOTHREONINE
HET TPO A 686 11
HET AU5 A1795 33
HET P4C A1796 22
HET P4C A1797 16
HET DMS A1798 4
HET DMS A1799 4
HET EDO A1800 4
HET EDO A1801 4
HET EDO A1802 4
HET EDO A1803 4
HET EDO A1804 4
HET EDO A1805 4
HET EDO A1806 4
HET EDO A1807 4
HET EDO A1808 4
HET EDO A1809 4
HET EDO A1810 4
HET EDO A1811 4
HET EDO A1812 4
HET DMS A1813 4
HETNAM TPO PHOSPHOTHREONINE
HETNAM AU5 9-CYCLOPENTYL-2-[[2-METHOXY-4-[(1-METHYLPIPERIDIN-4-
HETNAM 2 AU5 YL)OXY]-PHENYL]AMINO]-7-METHYL-7,9-DIHYDRO-8H-PURIN-8-
HETNAM 3 AU5 ONE
HETNAM P4C O-ACETALDEHYDYL-HEXAETHYLENE GLYCOL
HETNAM DMS DIMETHYL SULFOXIDE
HETNAM EDO 1,2-ETHANEDIOL
HETSYN TPO PHOSPHONOTHREONINE
HETSYN P4C POLYETHYLENE 400
HETSYN EDO ETHYLENE GLYCOL
FORMUL 1 TPO C4 H10 N O6 P
FORMUL 2 AU5 C24 H32 N6 O3
FORMUL 3 P4C 2(C14 H28 O8)
FORMUL 5 DMS 3(C2 H6 O S)
FORMUL 7 EDO 13(C2 H6 O2)
FORMUL 21 HOH *59(H2 O)
HELIX 1 1 ASP A 561 GLN A 579 1 19
HELIX 2 2 LEU A 609 LYS A 616 1 8
HELIX 3 3 ASP A 620 GLN A 640 1 21
HELIX 4 4 LYS A 649 ALA A 651 5 3
HELIX 5 5 PRO A 691 MET A 698 1 8
HELIX 6 6 SER A 712 GLY A 730 1 19
HELIX 7 7 ASN A 739 ASP A 749 1 11
HELIX 8 8 GLU A 761 LEU A 772 1 12
HELIX 9 9 SER A 781 ALA A 787 1 7
HELIX 10 10 HIS A 788 ILE A 793 1 6
SHEET 1 AA 6 SER A 517 VAL A 520 0
SHEET 2 AA 6 ARG A 523 SER A 533 -1 O ARG A 523 N VAL A 520
SHEET 3 AA 6 SER A 537 LEU A 543 -1 O VAL A 539 N ILE A 531
SHEET 4 AA 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542
SHEET 5 AA 6 TYR A 597 MET A 602 -1 O ILE A 598 N VAL A 555
SHEET 6 AA 6 LEU A 588 ILE A 593 -1 N TYR A 589 O VAL A 601
SHEET 1 AB 3 ILE A 607 ASP A 608 0
SHEET 2 AB 3 PHE A 653 VAL A 656 -1 N ILE A 655 O ILE A 607
SHEET 3 AB 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656
LINK C GLY A 685 N TPO A 686 1555 1555 1.36
LINK C TPO A 686 N VAL A 687 1555 1555 1.34
SITE 1 AC1 15 ILE A 531 VAL A 539 ALA A 551 ILE A 586
SITE 2 AC1 15 MET A 602 GLU A 603 CYS A 604 GLY A 605
SITE 3 AC1 15 ASN A 606 ILE A 607 ASP A 608 SER A 611
SITE 4 AC1 15 LEU A 654 P4C A1796 DMS A1798
SITE 1 AC2 10 SER A 537 VAL A 539 LYS A 553 TYR A 568
SITE 2 AC2 10 GLU A 571 MET A 600 MET A 602 ILE A 663
SITE 3 AC2 10 AU5 A1795 HOH A2012
SITE 1 AC3 9 ASN A 570 TRP A 622 LYS A 625 SER A 626
SITE 2 AC3 9 LYS A 629 VAL A 791 GLN A 792 ILE A 793
SITE 3 AC3 9 EDO A1806
SITE 1 AC4 5 GLN A 541 CYS A 604 GLY A 605 ASN A 606
SITE 2 AC4 5 AU5 A1795
SITE 1 AC5 4 TYR A 525 TYR A 550 VAL A 601 HOH A2057
SITE 1 AC6 6 ASP A 595 HIS A 636 HIS A 639 ILE A 782
SITE 2 AC6 6 EDO A1803 HOH A2056
SITE 1 AC7 4 ASN A 570 TYR A 574 GLN A 794 HOH A2058
SITE 1 AC8 4 ILE A 549 TYR A 589 CYS A 604 HOH A2006
SITE 1 AC9 4 THR A 594 ASP A 595 GLN A 596 EDO A1800
SITE 1 BC1 4 PRO A 760 GLU A 761 LYS A 762 ASP A 763
SITE 1 BC2 2 ARG A 774 ASP A 775
SITE 1 BC3 3 ASP A 566 GLN A 792 P4C A1797
SITE 1 BC4 5 ASN A 562 ASP A 566 ARG A 569 GLU A 633
SITE 2 BC4 5 EDO A1811
SITE 1 BC5 3 LEU A 613 LYS A 617 HOH A2049
SITE 1 BC6 3 ILE A 738 ASN A 739 SER A 742
SITE 1 BC7 4 TYR A 574 HIS A 641 ILE A 793 GLN A 794
SITE 1 BC8 5 HIS A 636 THR A 637 GLN A 640 EDO A1807
SITE 2 BC8 5 HOH A2016
SITE 1 BC9 4 TRP A 622 GLU A 623 SER A 626 GLY A 658
CRYST1 70.930 111.960 113.090 90.00 90.00 90.00 I 2 2 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.014098 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008932 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008843 0.00000